The American Journal of Managed Care: Postmenopausal Osteoporosis: Clinical Burden, Treatment Barriers, and the Evolving Role of Denosumab Biosimilars Postmenopausal Osteoporosis: Clinical Burden, Treatment Barriers, and the Evolving Role of Denosumab Biosimilars The Asia Pacific Consortium on Osteoporosis (APCO) has today launched the first pan-Asia Pacific clinical practice standards for the screening, diagnosis, and management of osteoporosis, targeting a ... Postmenopausal osteoporosis continues to be a growing and costly global public health challenge. In recent interviews conducted by the American Journal of Managed Care®, this topic was explored by ...
Postmenopausal women with systemic sclerosis had a high prevalence of osteoporosis, which was linked to impaired quality of life and worse patient-reported outcomes. Osteoporosis is significantly more ... Credit: Getty Images. By 2030, the number of adults with osteoporosis or low bone mass is estimated to increase by more than 30%, to 71 million.
osteoporosis clinical manifestations, The Conversation — Because there are typically no ... CNN on MSN: Concerned about osteoporosis? What helps prevent fractures beyond medication Osteoporosis — a significant drop in bone density — can lead to fractures and disability if left untreated. Here are ways to prevent and treat the condition.
